ArticleFrontiers in immunology2026

A prospective real-world study of efgartigimod in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Xiangtao Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.